EGFR and posterior cortical atrophy: Although in vitro cell models do not fully capture the complexity of PCa, the in vitro assessment of the impact of a coinhibition therapy targeting EGFR and STAT3 is aligned with the mechanistic observations in the same cell models, providing a rationale for its therapeutic efficacy in ETV1‐positive PCa.